Tomas Lenz

787 total citations
28 papers, 602 citations indexed

About

Tomas Lenz is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Tomas Lenz has authored 28 papers receiving a total of 602 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Surgery, 8 papers in Cardiology and Cardiovascular Medicine and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Tomas Lenz's work include Birth, Development, and Health (5 papers), Pregnancy and preeclampsia studies (4 papers) and Adrenal and Paraganglionic Tumors (4 papers). Tomas Lenz is often cited by papers focused on Birth, Development, and Health (5 papers), Pregnancy and preeclampsia studies (4 papers) and Adrenal and Paraganglionic Tumors (4 papers). Tomas Lenz collaborates with scholars based in Germany, United States and India. Tomas Lenz's co-authors include Jean E. Sealey, Phyllis August, Jan Goßmann, John H. Laragh, Helmut Geiger, Joachim Hoyer, Terri G. Edersheim, J. M. Hutson, Maurice L. Druzin and Kathy L. Aleš and has published in prestigious journals such as New England Journal of Medicine, The Journal of Clinical Endocrinology & Metabolism and Annals of the New York Academy of Sciences.

In The Last Decade

Tomas Lenz

26 papers receiving 577 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tomas Lenz Germany 12 242 149 121 119 118 28 602
Linda Woolf United Kingdom 6 210 0.9× 166 1.1× 99 0.8× 110 0.9× 106 0.9× 7 853
Susan C. Fox United Kingdom 16 321 1.3× 94 0.6× 49 0.4× 64 0.5× 36 0.3× 28 650
Riccardo Pin Switzerland 7 133 0.5× 71 0.5× 37 0.3× 404 3.4× 45 0.4× 8 876
Augusto Antonello Italy 14 157 0.6× 25 0.2× 69 0.6× 106 0.9× 95 0.8× 41 679
Toshio NISHIDE Japan 8 207 0.9× 40 0.3× 46 0.4× 287 2.4× 170 1.4× 27 644
R. Meleady Ireland 8 55 0.2× 91 0.6× 68 0.6× 332 2.8× 38 0.3× 14 842
Amret Hawfield United States 11 165 0.7× 161 1.1× 136 1.1× 42 0.4× 50 0.4× 15 574
Kotaro Haruhara Japan 16 149 0.6× 61 0.4× 182 1.5× 84 0.7× 111 0.9× 73 696
Jean Amiral France 10 104 0.4× 50 0.3× 34 0.3× 55 0.5× 31 0.3× 13 423
Chii-Yuan Jeng Taiwan 11 93 0.4× 70 0.5× 76 0.6× 88 0.7× 197 1.7× 18 431

Countries citing papers authored by Tomas Lenz

Since Specialization
Citations

This map shows the geographic impact of Tomas Lenz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomas Lenz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomas Lenz more than expected).

Fields of papers citing papers by Tomas Lenz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomas Lenz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomas Lenz. The network helps show where Tomas Lenz may publish in the future.

Co-authorship network of co-authors of Tomas Lenz

This figure shows the co-authorship network connecting the top 25 collaborators of Tomas Lenz. A scholar is included among the top collaborators of Tomas Lenz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomas Lenz. Tomas Lenz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lenz, Tomas & Karl-Ludwig Schulte. (2016). Current management of renal artery stenosis.. PubMed. 58(1). 94–101. 1 indexed citations
2.
Lenz, Tomas, C.M. Kirchmaier, Klaus Badenhoop, et al.. (2006). Multicenter Study on the Diagnostic Value of a New RIA for the Detection of Free Plasma Metanephrines in the Work‐Up for Pheochromocytoma. Annals of the New York Academy of Sciences. 1073(1). 358–373. 11 indexed citations
3.
Bergner, Raoul, Tomas Lenz, Dirk Henrich, Martin Hoffmann, & M. Uppenkamp. (2006). Proteinuria in Diabetic Patients – Is It Always Diabetic Nephropathy?. Kidney & Blood Pressure Research. 29(1). 48–53. 9 indexed citations
4.
Lenz, Tomas, Stefan Gauer, Herbert A. Weich, et al.. (2005). Vascular endothelial growth factor and its soluble receptor, Flt‐1, are not correlated to erythropoietin in diabetics with normal or reduced renal function. Nephrology. 10(1). 84–89. 2 indexed citations
5.
Lenz, Tomas, et al.. (2004). Nierenerkrankungen: cave Kalium!. Medizinische Klinik. 99(7). 355–361. 1 indexed citations
6.
Lenz, Tomas, et al.. (2003). Vascular Endothelial Growth Factor in Diabetic Nephropathy. Kidney & Blood Pressure Research. 26(5-6). 338–343. 26 indexed citations
7.
Goßmann, Jan, Sebastian Harder, Tomas Lenz, et al.. (2001). Angiotensin II infusion increases plasma erythropoietin levels via an angiotensin II type 1 receptor-dependent pathway. Kidney International. 60(1). 83–86. 82 indexed citations
8.
9.
Lenz, Tomas. (1997). Release of prorenin and placental hormones from superfused minced chorion laeve. Acta Obstetricia Et Gynecologica Scandinavica. 76(10). 903–906. 5 indexed citations
10.
Lenz, Tomas, et al.. (1997). Screening und Diagnostik zum Ausschluß einer renovaskulären Hypertonie. Medizinische Klinik. 92(6). 313–318. 1 indexed citations
11.
Lenz, Tomas. (1996). Prorenin and active renin in human fetal circulation. Acta Obstetricia Et Gynecologica Scandinavica. 75(3). 291–293. 6 indexed citations
12.
August, Phyllis, et al.. (1993). Comparative Renal Hemodynamic Effects of Lisinopril, Verapamil, and Amlodipine in Patients With Chronic Renal Failure. American Journal of Hypertension. 6(4S). 148S–154S. 8 indexed citations
13.
Hoyer, Joachim, et al.. (1993). Clinical Pharmacokinetics of Angiotensin Converting Enzyme (ACE) Inhibitors in Renal Failure. Clinical Pharmacokinetics. 24(3). 230–254. 53 indexed citations
14.
Schulte, Karl-Ludwig, et al.. (1993). Relationships Between Ambulatory Blood Pressure, Forearm Vascular Resistance, and Left Ventricular Mass in Hypertensive and Normotensive Subjects. American Journal of Hypertension. 6(9). 786–793. 23 indexed citations
15.
Lenz, Tomas, Jean E. Sealey, & Duane A. Tewksbury. (1993). Regional distribution of the angiotensinogens in human placentae. Placenta. 14(6). 695–699. 20 indexed citations
16.
Schulte, Karl-Ludwig, et al.. (1992). Relation of regression of left ventricular hypertrophy to changes in ambulatory blood pressure after long-term therapy with perindopril versus nifedipine. The American Journal of Cardiology. 70(4). 468–473. 31 indexed citations
17.
Lenz, Tomas, et al.. (1992). Hyperreninemia and Secondary Hyperaldosteronism in a Patient with Pheochromocytoma and von Hippel-Lindau Disease. ˜The œNephron journals/Nephron journals. 62(3). 345–350. 11 indexed citations
18.
August, Phyllis, Tomas Lenz, Kathy L. Aleš, et al.. (1990). Longitudinal study of the renin-angiotensin-aldosterone system in hypertensive pregnant women: Deviations related to the development of superimposed preeclampsia. American Journal of Obstetrics and Gynecology. 163(5). 1612–1621. 129 indexed citations
19.
Lenz, Tomas, Jean E. Sealey, Phyllis August, Gary D. James, & John H. Laragh. (1989). Tissue Levels of Active and Total Renin, Angiotensinogen, Human Chorionic Gonadotropin, Estradiol, and Progesterone in Human Placentas from Different Methods of Delivery*. The Journal of Clinical Endocrinology & Metabolism. 69(1). 31–37. 41 indexed citations
20.
Haller, Hermann, et al.. (1987). Changes in Sensitivity to Angiotensin II in Platelets. Journal of Cardiovascular Pharmacology. 10. S44–46. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Linda Woolf Breakdown of academic impact, for papers by Susan C. Fox Breakdown of academic impact, for papers by Riccardo Pin Breakdown of academic impact, for papers by Augusto Antonello Breakdown of academic impact, for papers by Toshio NISHIDE Breakdown of academic impact, for papers by R. Meleady Breakdown of academic impact, for papers by Amret Hawfield Breakdown of academic impact, for papers by Kotaro Haruhara Breakdown of academic impact, for papers by Jean Amiral Breakdown of academic impact, for papers by Chii-Yuan Jeng
Rankless by CCL
2026